Patent 7091021 was granted and assigned to Geron Corporation on August, 2006 by the United States Patent and Trademark Office.
The invention provides compositions and methods related to human telomerase reverse transcriptase (hTRT), the catalytic protein subunit of human telomerase. Catalytically active and inactive human telomerase reverse transcriptase variants comprising deletions or other mutations are provided.